Literature DB >> 11082473

Altered salivary dehydroepiandrosterone levels in major depression in adults.

A Michael1, A Jenaway, E S Paykel, J Herbert.   

Abstract

BACKGROUND: The authors sought to examine whether levels of dehydroepiandrosterone are abnormal in depression.
METHODS: Three groups of subjects aged 20-64 were studied: 44 major depressives, 35 subjects with partially or completely remitted depression, matched as far as possible for age and drug treatment, and 41 normal control subjects. Dehydroepiandrosterone and cortisol in saliva were determined from specimens taken at 8:00 AM and 8:00 PM on 4 days.
RESULTS: The mean age of the three groups did not differ. Dehydroepiandrosterone was lowered at 8:00 AM and 8:00 PM compared with control subjects. Values for the remitted group were intermediate. Dehydroepiandrosterone levels at 8:00 AM correlated negatively with severity of depression and were not related to drug treatment or smoking, but decreased with age (as expected). Cortisol was elevated in depression in the evening. The molar cortisol/dehydroepiandrosterone ratio also differentiated those with depression from the control group.
CONCLUSIONS: Lowered dehydroepiandrosterone levels are an additional state abnormality in adult depression. Adrenal steroid changes are thus not limited to cortisol. Because dehydroepiandrosterone may antagonize some effects of cortisol and may have mood improving properties, these findings may have significant implications for the pathophysiology of depression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082473     DOI: 10.1016/s0006-3223(00)00955-0

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  36 in total

Review 1.  Role of circadian neuroendocrine rhythms in the control of behavior and physiology.

Authors:  Henryk F Urbanski
Journal:  Neuroendocrinology       Date:  2011-04-21       Impact factor: 4.914

Review 2.  The role of reproductive hormones in postpartum depression.

Authors:  Crystal Edler Schiller; Samantha Meltzer-Brody; David R Rubinow
Journal:  CNS Spectr       Date:  2014-09-29       Impact factor: 3.790

Review 3.  Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?

Authors:  Shannon K Crowley; Susan S Girdler
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

4.  Concurrent and prospective associations between HPA axis activity and depression symptoms in newlywed women.

Authors:  Fiona Ge; Paula R Pietromonaco; Casey J DeBuse; Sally I Powers; Douglas A Granger
Journal:  Psychoneuroendocrinology       Date:  2016-07-22       Impact factor: 4.905

5.  Genetic and environmental effects on diurnal dehydroepiandrosterone sulfate concentrations in middle-aged men.

Authors:  Elizabeth C Prom-Wormley; Timothy P York; Kristen C Jacobson; Lindon J Eaves; Sally P Mendoza; Dirk Hellhammer; Nicole Maninger; Seymour Levine; Sonia Lupien; Michael J Lyons; Richard Hauger; Hong Xian; Carol E Franz; William S Kremen
Journal:  Psychoneuroendocrinology       Date:  2011-05-12       Impact factor: 4.905

6.  Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized/castrated mice via both 5-HT reuptake inhibition and σ(1) receptor activation.

Authors:  Yukio Ago; Koji Yano; Naoki Hiramatsu; Kazuhiro Takuma; Toshio Matsuda
Journal:  Psychopharmacology (Berl)       Date:  2011-04-13       Impact factor: 4.530

7.  Etiologic specificity of waking Cortisol: Links with maternal history of depression and anxiety in adolescent girls.

Authors:  Brandon L Goldstein; Greg Perlman; Roman Kotov; Joan E Broderick; Keke Liu; Camilo Ruggero; Daniel N Klein
Journal:  J Affect Disord       Date:  2016-10-11       Impact factor: 4.839

8.  Determination of cortisol and dehydroepiandrosterone levels in saliva for screening of periodontitis in older Japanese adults.

Authors:  Toshihiro Ansai; Inho Soh; Aiko Ishisaka; Akihiro Yoshida; Shuji Awano; Tomoko Hamasaki; Kazuo Sonoki; Yutaka Takata; Tadamichi Takehara
Journal:  Int J Dent       Date:  2010-02-01

Review 9.  Dehydroepiandrosterone and age-related cognitive decline.

Authors:  Krystina G Sorwell; Henryk F Urbanski
Journal:  Age (Dordr)       Date:  2009-08-27

10.  Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women.

Authors:  Melinda L Morgan; Andrea J Rapkin; Giovanni Biggio; Mariangela Serra; Maria Giuseppina Pisu; Natalie Rasgon
Journal:  Arch Womens Ment Health       Date:  2009-09-03       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.